CEK-10930-61555
3 vaccinations
2 coded responses
20 check-ins
2 free-text entries
3 call cases
- Sex
- Female
- Age at first dose
- 46-50
- ZIP prefix
- 330 / FL
- Registered
- 2020-12-29
- Relationship
- Self
- Race
- N/A
- Ethnicity
- N/A
Timeline
-
2020-12-29
Registered in v-safe
-
2020-12-29
Dose 1 — Pfizer-BioNTech
-
2020-12-30
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain, Swelling · Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2020-12-30
Report sent to call center — days 1–6 daily, dose 1Be unable to do your normal daily activities1 call case(s)
-
2020-12-31
Health check-in — days 1–6 daily, dose 1Feeling: Good · Headache, Fatigue or tirednessAdult check-in
- 2021-01-02
- 2021-01-03
- 2021-01-05
- 2021-01-14
-
2021-01-20
Dose 2 — Pfizer-BioNTech
-
2021-01-26
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-01-27
- 2021-02-19
- 2021-02-24
- 2021-03-03
- 2021-04-21
- 2021-07-23
-
2021-09-09
Dose 3 — Moderna
-
2021-09-29
Survey response — day 14, dose 3MedDRA: Chest discomfort, Office visit — Feeling: Fair · Get care from a doctor or other healthcare professionalFree text: Symptoms: Chest tightness · Healthcare visit (other): Cardiology vistMedDRA releases: 2024-11 · check-in free text available
-
2021-09-29
Report sent to call center — day 14, dose 3Get care from a doctor or other healthcare professional1 call case(s)
- 2021-09-30
- 2021-10-07
- 2021-10-14
- 2021-10-21
- 2021-12-09
-
2022-03-12
Survey response — 6 months, dose 3MedDRA: COVID-19, Cough, Dyspnoea, Impaired work ability, Quarantine, Unevaluable event — Feeling: Good · Be unable to work or attend school, Get care from a doctor or other healthcare professionalFree text: Symptoms: Covid-19, I had coughing and an episode of shortness of breath. I missed 1 day of work however was able to self quarantine for 5 days after monoclonal antibodies received. Cough and shortness of breath resolved. · Healthcare visit (other): Monoclonal antibodiesMedDRA releases: 2024-11 · check-in free text available
-
2022-03-12
Report sent to call center — 6 months, dose 3Be unable to work or attend school · Get care from a doctor or other healthcare professional1 call case(s)
- 2022-03-14
- 2022-09-09
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-29 | Pfizer-BioNTech | |
| 2 | 2021-01-20 | Pfizer-BioNTech | |
| 3 | 2021-09-09 | Moderna | No |
Call center
3 call center cases
2 unsuccessful · 1 priority 2/3 (triaged and no follow up)
Free text
Release 9 — day 14, dose 3
Release 11 — 6 months, dose 3
Symptoms: Covid-19, I had coughing and an episode of shortness of breath. I missed 1 day of work however was able to self quarantine for 5 days after monoclonal antibodies received. Cough and shortness of breath resolved.
Healthcare visit (other): Monoclonal antibodies
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | · | · | ✓ |
| HCVO | Unevaluable event | · | · | ✓ |
| SD | Chest discomfort | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Dyspnoea | · | · | ✓ |
| SD | Impaired work ability | · | · | ✓ |
| SD | Quarantine | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release